Evidence map›Paper›PMID 26500614›Full record

ArticleFrontiers in microbiology2015

Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar metabolism.

Laura Paixão, José Caldas, Tomas G Kloosterman, Oscar P Kuipers, Susana Vinga, Ana R Neves

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Streptococcus pneumoniae GAPN is a key metabolic player necessary for host infection.Protein science : a publication of the Protein Society · 2025
    Article
  6. Article
  7. Comparative analysis of theFrontiers in microbiology · 2025
    Article
  8. Article
  9. Identification ofJournal of bacteriology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Combining the In Silico and In Vitro Assays to IdentifyPharmaceuticals (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Uncovering the link between theFrontiers in cellular and infection microbiology · 2023
    Article
  17. Inoculation withFrontiers in microbiology · 2023
    Article
  18. Carbon source-dependent capsule thickness regulation inFrontiers in cellular and infection microbiology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Laura PaixãoLaboratory of Lactic Acid Bacteria and In Vivo NMR, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa Oeiras, Portugal.
José CaldasCenter of Intelligent Systems, Instituto de Engenharia Mecânica, Instituto Superior Técnico, Universidade de Lisboa Lisboa, Portugal.
Tomas G KloostermanDepartment of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen Groningen, Netherlands.
Oscar P KuipersDepartment of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen Groningen, Netherlands.
Susana VingaCenter of Intelligent Systems, Instituto de Engenharia Mecânica, Instituto Superior Técnico, Universidade de Lisboa Lisboa, Portugal.
Ana R NevesLaboratory of Lactic Acid Bacteria and In Vivo NMR, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa Oeiras, Portugal.
Universidade Nova de Lisboa · PTUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is a strictly fermentative human pathogen that relies on carbohydrate metabolism to generate energy for growth. The nasopharynx colonized by the bacterium is poor in free sugars, but mucosa lining glycans can provide a source of sugar. In blood and inflamed tissues glucose is the prevailing sugar. As a result during progression from colonization to disease S. pneumoniae has to cope with a pronounced shift in carbohydrate nature and availability. Thus, we set out to assess the pneumococcal response to sugars found in glycans and the influence of glucose (Glc) on this response at the transcriptional, physiological, and metabolic levels. Galactose (Gal), N-acetylglucosamine (GlcNAc), and mannose (Man) affected the expression of 8 to 14% of the genes covering cellular functions including central carbon metabolism and virulence. The pattern of end-products as monitored by in vivo (13)C-NMR is in good agreement with the fermentation profiles during growth, while the pools of phosphorylated metabolites are consistent with the type of fermentation observed (homolactic vs. mixed) and regulation at the metabolic level. Furthermore, the accumulation of α-Gal6P and Man6P indicate metabolic bottlenecks in the metabolism of Gal and Man, respectively. Glc added to cells actively metabolizing other sugar(s) was readily consumed and elicited a metabolic shift toward a homolactic profile. The transcriptional response to Glc was large (over 5% of the genome). In central carbon metabolism (most represented category), Glc exerted mostly negative regulation. The smallest response to Glc was observed on a sugar mix, suggesting that exposure to varied sugars improves the fitness of S. pneumoniae. The expression of virulence factors was negatively controlled by Glc in a sugar-dependent manner. Overall, our results shed new light on the link between carbohydrate metabolism, adaptation to host niches and virulence.

Indexed as

glucoseglycan-derived sugarsin vivo13C-NMRStreptococcus pneumoniaetranscriptome

Identifiers

PMID26500614
PMCPMC4595796
OpenAlexW1918655545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.